AGN
Price sensitive
Clinical Advisory Committee Established to Advance Phase 2b
Argenica Therapeutics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in